dsip portfolio first trust Daniel Blong DoD's 115 Open Problems with

Purity & Testing Purity verified at 99.0% by HPLC

High-quality, pharmaceutical-grade B12

What the Research Says About Safety Clinical studies on AOD9604 indicate that the peptide is generally welltolerated: In human trials, no significant adverse effects were reported at doses up to 1 mg/day (safety summary) Unlike growth hormone therapies, AOD9604 does not meaningfully elevate IGF1 levels (human data), which may reduce the risk of unwanted growthrelated side effects

Benzyl alcohol prevents bacterial growth, allowing for multiple-dose use via intravenous or intramuscular injection

Copper peptides can be sensitive to formulation conditions, and the copper that gives the molecule its activity can also participate in oxidative chemistry if a product is poorly formulated